Fierce Pharma
JUNE 28, 2024
After scoring approval as the world’s first pneumococcal disease vaccine made specifically for adults earlier this month, Merck’s Capvaxive passed the next test in its bid to take on Pfizer an | The recommendation sets up Merck's new pneumococcal disease vaccine to potentially capture some of Pfizer's market share.
pharmaphorum
JUNE 28, 2024
The House Ways and Means Committee in the US voted in favour of a new bill which would end a two-decade-long restriction on the coverage of drugs to treat obesity under Medicare.The Treat and Reduce Obesity Act of 2023 (TROA) was originally intended to overturn the restriction completely, but has been hugely scaled back in its scope.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JUNE 28, 2024
An antibody-drug conjugate patent arbitration fight that Seagen waged against Daiichi Sankyo has officially ended in a win for the Japanese company. | An antibody-drug conjugate patent arbitration fight that Seagen waged against Daiichi Sankyo has officially ended in a win for the Japanese company.
MedCity News
JUNE 28, 2024
By prioritizing data accuracy and interoperability, stakeholders can begin to unlock the potential of AI in healthcare. The post How AI Can Help Solve Healthcare’s Data Problem appeared first on MedCity News.
Fierce Pharma
JUNE 28, 2024
For the second time in six months, Europe’s CHMP has given a thumbs down to Apellis’ Syfovre for the treatment of patients with geographic atrophy.
MedCity News
JUNE 28, 2024
Rick Ratliff, a pharmacy industry veteran who was for a time CEO of Surescripts, built a national digital prescription network connecting doctors to pharmacies. The post Pivot Podcast: The Evolution of Pharmacies with Rick Ratliff appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JUNE 28, 2024
This week, health data platform Arcadia acquired CareJourney, a health analytics firm designed to facilitate participation in value-based care contracts. The deal combines Arcadia’s data platform, analytics and workflow tools with CareJourney’s trove of data on cost, quality and benchmarks. The post Arcadia & CareJourney Merge to Take Value-Based Care Analytics to Another Level appeared first on MedCity News.
pharmaphorum
JUNE 28, 2024
Amazon’s strategy in telehealth has coalesced around a pay-per-visit and subscription-based model under a new brand – Amazon One Medical.
MedCity News
JUNE 28, 2024
In this month’s episode, Senior Reporter Katie Adams explored some executive moves and layoffs that recently occurred in the healthcare world. She also interviewed Rod Hochman, who is retiring from his role as CEO of Providence after a 45-year career in healthcare. The post MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Rod Hochman, CEO of Providence appeared first on MedCity News.
Pharmaceutical Commerce
JUNE 28, 2024
The latest news for pharma industry insiders.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
JUNE 28, 2024
Highly sophisticated brokers and their transportation provider networks have invested in these improvements that have reshaped the industry The post Four Improvements Driving Positive Change in the Medical Transportation Industry appeared first on MedCity News.
Referral MD
JUNE 28, 2024
Patient referrals play a crucial role in the healthcare system, allowing for the seamless transfer of patients between healthcare providers while ensuring continuity of care. However, the process of referrals can often be complex and inefficient, leading to challenges such as lost referrals, delays in care, and miscommunication between providers. Closing the referral loop is essential in optimizing the patient referral process and improving patient outcomes.
MedCity News
JUNE 28, 2024
A new report from JPMorgan Chase showed that small businesses are struggling with the cost of health insurance. The post JPMorgan Chase: Health Insurance Premiums Are Burdening Small Businesses appeared first on MedCity News.
LEVO Health
JUNE 28, 2024
Generation Z, the cohort born between 1997 and 2012, is a dynamic and digitally-native group that requires a fresh and innovative approach to healthcare marketing. Defined by their constant connectivity, tech proficiency, and a strong desire for authenticity, Gen Z has grown up with smartphones and social media, navigating the digital world with ease.
MedCity News
JUNE 28, 2024
Alumis’s lead drug candidate blocks TYK2, an inflammation target that’s already addressed by Sotyktu, a Bristol Myers Squibb drug approved for plaque psoriasis. Alumis plans to begin two Phase 3 tests in this indication later this year. The post Inflammation Biotech Alumis Trims IPO Plans But Still Raises $250M for Clinical Trials appeared first on MedCity News.
PharmExec
JUNE 28, 2024
The inclusion of Vaxelis in the CDC’s preferential recommendations is expected to influence vaccine administration strategies and public health policies in high-risk populations moving forward.
Impetus Digital
JUNE 28, 2024
Pharma-exclusive Webinar: Virtual Publication Planning, Co-Development, & Reviews About the webinar Join our exclusive small-group webinars to dive deep into the trends, strategies, and tips on all things Medical Publications. Learn from our expert speakers about the latest best practices for planning, co-developing, and reviewing publications and other medical materials such as peer-reviewed journal articles and consensus papers, conference abstracts and posters, educational slide decks, an
European Pharmaceutical Review
JUNE 28, 2024
Harnessing microbial identification data to boost confident decision-making Charles River highlights the significant role data integrity plays in contamination control strategies. Data integrity and AI: how pharma can build a data-driven future LabVantage Solutions explains that data integrity remains a core responsibility – and challenge – as pharmaceutical organisations seek to leverage AI and data lakes to grow, innovate and serve patients.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
PharmExec
JUNE 28, 2024
In an interview with Pharm Exec Associate Editor Don Tracy, Leonard Mazur, Co-founder, CEO, Citius Pharmaceuticals, offers an update on the recently accepted Biologics License Application for Lymphir by the FDA and other candidates currently in the Citius pipeline.
European Pharmaceutical Review
JUNE 28, 2024
Credit: Suanfarma CDMO Register to discover the full article on why biofermentation benefits from additional processing to produce a viable drug candidate. The supply of complex structures from natural sources is very costly or technically unfeasible due to their scarcity. Therefore, it is essential to have technological alternatives that overcome the problem for the commercial supply chain that do not hinder the development of new therapeutic agents.
Pharmaceutical Technology
JUNE 28, 2024
As the largest service provider in the NHS, primary care delivers over 300 million patient consultations annually. In the evolving landscape of clinical research, the data held in primary care Electronic Health Records (EHR) has been recognised for the significant potential it offers in uncovering insights, driving innovation, and enhancing patient care.
European Pharmaceutical Review
JUNE 28, 2024
Register your details to discover more about the evolving technology for drug substance manufacturing A noteworthy milestone was in 2007, when a grant from Novartis to MIT led to the creation of the Novartis-MIT Center for Continuous Manufacturing, an ambitious multi-investigator programme to integrate continuous drug substance and drug product manufacturing. 1 There are several reasons why the adoption of continuous manufacturing (CM) for drugs lagged applications elsewhere.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
JUNE 28, 2024
In this article John McCormack, Executive Director of Research & Life Sciences, explores how unlocking the potential of healthcare technology can enable healthcare teams to work more safely and efficiently to drive improved patient outcomes.
Scott Burrows
JUNE 28, 2024
In the chaos of the Hotel Airport in Orlando, I found myself seated next to a man whose story would leave a mark on me. Little did I know that this chance encounter with John Waggoner would ignite a conversation that would inspire me to reflect on the principles of Vision , Mindset , and Grit. As we exchanged pleasantries over dinner, our conversation took an unexpected turn when I shared that I was the keynote speaker for the Transportation Expressway Members of Florida (TEAM) Leadership &
Clarivate
JUNE 28, 2024
The artificial intelligence (AI) revolution has created a remarkable opportunity to transform medical diagnostics by significantly enhancing the accuracy, speed, and efficiency of diagnosing patients. AI algorithms analyze medical images, such as X-rays, MRIs, ultrasounds, CT scans, and DXA ( dual energy X-ray absorptiometry) scans. AI can process vast amounts of patient data, including 2D/3D imaging, bio-signals, electronic health records, as well as demographic information, medical history, an
Pharmaceutical Technology
JUNE 28, 2024
AbbVie has acquired Celsius Therapeutics, a company that focuses on developing new treatments for inflammatory diseases, for $250m in cash.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Pharmaceutical Commerce
JUNE 28, 2024
A cross-sectional audit study determines how racial and ethnic disparities—among English, Mandarin, and Spanish-speaking patients—can impact access.
Pharmaceutical Technology
JUNE 28, 2024
The EMA's CHMP has recommended granting marketing authorisation for Pfizer and BioNTech’s Omicron JN.1-adapted Covid-19 vaccine.
PharmaTech
JUNE 28, 2024
The typical cycle of ceasing and then reinitiating fremanezumab treatments may actually result in increased monthly migraine days, the study said.
Pharmaceutical Technology
JUNE 28, 2024
Eisai and Biogen have announced the introduction of LEQEMBI (lecanemab) for the treatment of Alzheimer's disease (AD) in China.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Expert insights. Personalized for you.
256 
Let's personalize your content